Cathie Wood’s ARK line of ETFs added more 29,845 Tempus AI (TEM) stock after the company announced the acquisition of Deep 6 AI ...

AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and market outlook.

We recently published a list of Top 10 Stocks Everyone Is Talking About These Days. In this article, we are going to take a ...

Manus structured tasks well but stumbled in execution, hallucinating data and creating clunky designs.

Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed ...

Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook for long-term growth and profitability. The company uses AI to manage patient testing and help ...

The medical technology firm's non-GAAP operating expenses rose 6.5% year-over-year as the company expanded operations. Tempus AI gave weaker-than-expected guidance for full-year adjusted EBITDA.

JPMorgan analyst Rachel Vatnsdal downgrades Tempus AI from Overweight to Neutral following the company's quarterly results. Every week, our Whisper Index uncovers five overlooked stocks with big ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the ...